AstraZeneca Plc is facing a proposed class action lawsuit saying the drugmaker artificially inflated its US stock price by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback